AXGN 14.69 (+2.8%)
US05463X1063Medical Devices & InstrumentsMedical Devices

Axogen (AXGN) Stock Highlights

14.69 | +2.8%
2024-09-18 04:19:19
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically proven and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, United Kingdom, Spain, South Korea, and several other countries.

Statistics

Range Today
14.29 14.88
Volume Today 779.4K
Range 1 Year
3.45 14.5
Volume 1 Year 106.16M
Range 3 Year
3.45 16.77
Volume 3 Year 237.72M
Range 10 Year
2.14 56.85
Volume 10 Year 743.92M

Highlights

Market Capitalization 604.41M (small)
Floating Shares 35.65M
Current Price 14.69
Price To Earnings -35.03
Price To Revenue 3.72
Price To Book 6.32
Earnings Per Share -0.39
Payout Ratio 0%

Performance

Latest +2.8%
1 Month +24.91%
3 Months +93.54%
6 Months +91.28%
1 Year +168.07%
3 Years -8.36%
5 Years +4.78%
10 Years +547.14%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.